CongressBuys

Rep. Kevin Hern sold Johnson & Johnson (JNJ)

Rep. Kevin Hern (R-OK-1) · $100K–$250K · traded Dec 31, 2024

Transaction
Sold (full)
Amount
$100K–$250K
Owner
Joint
Traded
Dec 31, 2024
Disclosed
Jan 15, 2025
Days to disclose
15
Asset type
Stock
As filed
Johnson & Johnson Common Stock
Industry
Drug Manufacturers - General · Healthcare

Other trades in this filing

Recent Congress trades in JNJ

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.